Skip to content

Efficacy of Midodrine for the Prevention of Orthostatic Hypotension During Early Mobilization After Fast-track Hip Arthroplasty

Efficacy of Midodrine for the Prevention of Orthostatic Hypotension During Early Mobilization After Fast-track Hip Arthroplasty - a Randomized, Placebo Controlled Trial.

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01707953
Enrollment
120
Registered
2012-10-16
Start date
2012-10-31
Completion date
2013-09-30
Last updated
2014-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Orthostatic Hypotension, Postoperative Orthostatic Intolerance

Brief summary

The aim of this study is to examine the efficacy of 5 mg Midodrine (Gutron) vs. placebo on reducing the incidence of orthostatic hypotension during mobilization 6 h after a total hip arthroplasty.

Interventions

DRUGMidodrine

Midodrine 5mg as capsule, administered twice (5 and 23 hours after end of surgery).

DRUGPlacebo

Placebo capsule to mimic midodrine

Sponsors

Rigshospitalet, Denmark
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Scheduled for primary unilateral hip arthroplasty * Age \>= 18 years * Able to give informed consent

Exclusion criteria

* General anaesthesia for the current procedure * Digoxin treatment. * history of renal or hepatic failure * history of glaucoma * history chronic urinary retention requiring treatment * history of orthostatic intolerance / hypotension * other autonomous nervous system disease * alcohol or drug abuse * current malignant disease * females in the fertile age (possible pregnancy or breast feeding) * Treatment with anticoagulants * BMI \> 40 kg/m2 * Dementia or cognitive dysfunction (investigators evaluation)

Design outcomes

Primary

MeasureTime frameDescription
Orthostatic hypotension6 hours after surgeryOrthostatic hypotension (OH) during early mobilization 6 hours after end of surgery. OH is classified according to international consensus.

Secondary

MeasureTime frameDescription
Orthostatic hypotension 24 hours after surgery24 hours after end of surgery.
Orthostatic Intolerance6 and 24 hours after end of surgeryOrthostatic intolerance is defined as subjective presyncopal symptoms (dizziness, nausea etc.) during mobilization after surgery
Treatment side effects6 and 24 hours after end of surgeryThe following side effects to Midodrine are evaluated: * Pruritus * Headache * Supine hypertension * Urinary retention

Other

MeasureTime frameDescription
Haemodynamic response to mobilization 6 and 24 hours after surgery6 and 24 hours after end of surgeryHaemodynamic response to mobilization (supine, sitting and standing): * Response in systolic and diastolic blood pressure * Response in heart rate. * Response in calculated haemodynamic variables (stroke volume, peripheral resistance)
Heart rate variabilitybefore surgery, 6- and 24 hours after surgeryHeart rate variability measures including spectral analysis and LF/HF ratio at rest and during mobilization.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026